费诺纤维酸通过减少肥胖卵巢切除小鼠组织炎症来缓解胰岛素耐药性
Jungu Lee1, Suyeon Jeon1, Mijeong Lee1
1Department of Biological Sciences, Mokwon University, Daejeon, 35349, Korea.
Nutrition & diabetes
|November 7, 2023
概括
在模仿更年期后肥胖症的小鼠中,费诺纤维酸治疗降低了体重,改善了胰岛素抵抗和葡萄糖耐受性. 该药物还降低了胰腺炎症和瘤亡因子α (TNFα) 的表达.
科学领域:
- 内分泌学和新陈代谢学
- 药理学 药理学是指药理学的学科.
背景情况:
- 费诺纤维酸是一种低脂性药物,向氧酶增殖器激活受体α (PPARα).
- 它在临床上用于管理高胆固醇血症和高甘油三血症.
研究的目的:
- 为了研究纤维酸对胰岛素抵抗和组织炎症的影响.
- 使用高脂肪饮食 (HFD) 养的卵巢切除 (OVX) 鼠标模型,模拟肥胖的绝经后妇女.
主要方法:
- 在9周的时间里,OVX小鼠被食低脂肪饮食,高脂肪饮食或高脂肪饮食与纤维酸盐.
- 通过血液,组织学,免疫组织化学和qPCR分析评估胰岛素抵抗和炎症.
主要成果:
- 纤维酸减少了体重增加,脂肪组织质量和脂肪细胞大小,而不会影响食物摄入量.
- 改善了高血糖,高胰岛素,耐葡萄糖和胰腺β细胞功能.
- 在脂肪组织和血清中减少胰腺脂质积累,巨细胞透和TNFα表达.
结论:
- 费诺纤维酸治疗减弱了HFD食OVX小鼠的胰岛素耐药性.
- 这种效应部分通过减少组织炎症和TNFα表达来调节.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
212
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
212
Dipeptidyl Peptidase 4 Inhibitors
191
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
191


